Cargando…

晚期肺腺癌靶向耐药后小细胞癌转化2例并文献复习

Treatment of advanced non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutation with EGFR-tyrosine kinase inhibitors (EGFR-TKIs) can achieve good disease control, but it will inevitably produce drug resistance. About 3%-10% of the resistance mechanism is small...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720681/
https://www.ncbi.nlm.nih.gov/pubmed/36419397
http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.41